Rapid emergence of HIV-1 resistance to R82913 in only a minority of treated patients

Anne‐Mieke Vandamme; Zeger Debyser; Rudi Pauwels; K Andries; Paj Janssen; Jan Desmyter; De Clercq Erik

Related publications

Article1994

Characterization of HIV-1 Strains Isolated from Patients Treated with TIBO R82913

Anne‐Mieke Vandamme, Zeger Debyser, Rudi Pauwels, K De Vreese, Patrick Goubau, Mike Youle, Brian Gazzard, Paul Stoffels, G. Cauwenbergh, Jozef Anné, Koen Andries, Paul A. J. Janssen, Jan Desmyter, De Clercq Erik

Letter1994

How to overcome resistance of HIV-1 to HIV-1-specific reverse transcriptase inhibitors

De Clercq Erik

Article1996

Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)

Jean‐Claude Schmit, Lı́dia Ruiz, Bonaventura Clotet, Antoni Raventós, Jordi Tor, John M. Leonard, Jan Desmyter, De Clercq Erik, Anne‐Mieke Vandamme

Article1998

Selective PCR for the detection of HIV-1 drug resistance mutations in the follow-up of HIV-1 infected patients

Kristel Van Laethem, Kristien Van Vaerenbergh, JC Schmit, De Vroey, Rob Schuurman, S Sprecher, P Hermans, De Clercq Erik, Jan Desmyter, Anne‐Mieke Vandamme

Article2001

Prevalence of Genotypic Resistance among Antiretroviral Drug-Naive HIV-1-Infected Patients in Belgium

Kristien Van Vaerenbergh, Laurent Debaisieux, Nancy De Cabooter, Cathérine Declercq, K. Desmet, Katrien Fransen, Bart Maes, D. Marissens, Katherine M. Miller, Gaëtan Muyldermans, S Sprecher, Lieven Stuyver, D. Vaira, Chris Verhofstede, Georges Zissis, Marc Van Ranst, De Clercq Erik, Jan Desmyter, Anne‐Mieke Vandamme